We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

21 hedge funds and large institutions have $37.8M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

5% more funds holding

Funds holding: 20 → 21 (+1)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

45% less capital invested

Capital invested by funds: $68.2M → $37.8M (-$30.4M)

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$1.53M
2
Citigroup
Citigroup
New York
+$1.36M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$887K
4
Bank of America
Bank of America
North Carolina
+$50.7K
5
TRCT
Tower Research Capital (TRC)
New York
+$13.8K

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$1.77M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.18M
3
ECM
ExodusPoint Capital Management
New York
-$107K
4
TD Asset Management
TD Asset Management
Ontario, Canada
-$43.7K
5
UBS Group
UBS Group
Switzerland
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Cormorant Asset Management
Massachusetts
$11.1M – – –
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$9.8M -$1.77M -260,674 -11%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$7.34M -$1.18M -173,238 -10%
FCM
4
Farallon Capital Management
California
$3.92M – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.48M +$887K +130,400 +75%
Millennium Management
6
Millennium Management
New York
$1.09M +$1.53M +225,557 New
Citigroup
7
Citigroup
New York
$968K +$1.36M +200,000 New
O
8
OrbiMed
New York
$554K – – –
BCM
9
Bridgeway Capital Management
Texas
$339K – – –
Alyeska Investment Group
10
Alyeska Investment Group
Illinois
$305K – – –
TD Asset Management
11
TD Asset Management
Ontario, Canada
$246K -$43.7K -6,425 -11%
IHAM
12
Integral Health Asset Management
New York
$146K – – –
Bank of America
13
Bank of America
North Carolina
$115K +$50.7K +7,453 +46%
LCM
14
Laurion Capital Management
New York
$101K – – –
V
15
Veritable
Delaware
$100K – – –
BlackRock
16
BlackRock
New York
$89K +$3.2K +470 +3%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$73K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$13K +$13.8K +2,034 +270%
MIFH
19
Migdal Insurance & Financial Holdings
Israel
$5K -$4.49K -660 -38%
ECM
20
ExodusPoint Capital Management
New York
– -$107K -12,073 Closed
UBS Group
21
UBS Group
Switzerland
– -$13K -1,430 Closed
Morgan Stanley
22
Morgan Stanley
New York
– +$7 +1 New

LBPH Hedge Fund Activity: Q4 2021 in Review

21 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q4 2021, worth a combined $37.8M — down 45% from $68.2M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new LBPH positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.53M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.77M.

  • 21 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q4 2021, up from 20 in Q3 2021.
  • Funds reported $37.8M of Longboard Pharmaceuticals, Inc. Common Stock stock for Q4 2021, down 45% quarter-over-quarter.
  • 3 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q4 2021 and 2 closed out, a net change of +1 holder.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q4 2021 was Millennium Management, an estimated $1.53M added.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q4 2021 was T. Rowe Price Associates, an estimated $1.77M sold.

Based on aggregated 13F filings for Q4 2021.